One of the key factors driving the market forward is the rising prevalence of urinary tract infections (UTIs) in developing countries. If left untreated, urinary tract infections (UTIs) can progress to the kidneys and cause birth complications in pregnant women, which is a significant factor driving market growth.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-urinalysis-market
Data Bridge Market Research analyses that the urinalysis market is expected to grow at a CAGR of 7.3% in the forecast period of 2020 to 2027 and is expected to reach USD 8,767.60 million by 2027.
The growing prevalence of chronic kidney diseases worldwide is expected to drive the market's growth rate
The prevalence of age-related illnesses such as diabetes, liver disease, and renal disease is expected to rise significantly as the senior population grows, accelerating the market's expansion.
Furthermore, the 13.3 million people worldwide who suffer from acute kidney injury (AKI) each year are at risk of developing CKD or renal failure in the coming years, which is expected to fuel market growth.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2020 to 2027
|
Base Year
|
2019
|
Historic Years
|
2018 (Customizable to 2012 - 2017)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Type (Lithium Cobalt Oxide (LCO), Lithium Manganese Oxide (LMO), Lithium Nickel Manganese Cobalt Oxide (LI-NMC), Lithium Iron Phosphate (LFP), Lithium Nickel Cobalt Aluminum Oxide (NCA) and Lithium Titanate Oxide (LTO)), Component (Anode, Cathode, Electrolytic and Separator), Power Capacity (Below 3000 mAh, 3000 mAh to 10000 mAh, 10000 mAh to 60000 mAh and Above 60000 mAh), Product (Cell, Module, Pack and Energy Storage System (ESS)), Vertical (Automotive, Consumer Electronics, Aerospace and Defense, Industrial, Construction, Power, Telecom, Marine and Others)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
Market Players Covered
|
Abbott (U.S.), Siemens (Germany), BD (U.S.), Thermo Fisher Scientific (U.S.), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Beckman Coulter Inc. (U.S.), ACON Laboratories Inc. (U.S.), ARKRAY Inc. (Japan), Trinity Biotech (Ireland), Quidel Corporation (U.S.), ACON Laboratories Inc. (U.S.), Sysmex Corporation (Japan), Analyticon Biotechnologies Ag (Germany), Ekf Diagnostics (U.K.), Hti Medical Inc. (U.S.), Teco Diagnostics (U.S.), Tenko Medical System Corp (U.S.), Wama Diagnostica (Brazil)
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
Global urinalysis market is segmented into six notable segments which are based on the testing type, product, modality, application, end user and distribution channel.
In 2020, the urine biochemistry testing segment is expected to dominate the urinalysis market
The urine biochemistry testing segment is expected to dominate the urinalysis market with 49.46% market share due to the growing advancement in the testing operations with the help of technology.
In 2020, the urinary tract infections segment is expected to dominate the urinalysis market
The urinary tract infections segment is expected to dominate the urinalysis market with 49.46% market share due to growing prevalence of urinary infections as it is considered as the most common outpatient infections with a life time incidence of more than 60% in adult women.
Major Players
Data Bridge Market Research recognizes the following companies as the major urinalysis market players in urinalysis market are Abbott (U.S.), Siemens (Germany), BD (U.S.), Thermo Fisher Scientific (U.S.), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Beckman Coulter Inc. (U.S.), ACON Laboratories Inc. (U.S.), ARKRAY Inc. (Japan), Trinity Biotech (Ireland), Quidel Corporation (U.S.), ACON Laboratories Inc. (U.S.), Sysmex Corporation (Japan), Analyticon Biotechnologies Ag (Germany), Ekf Diagnostics (U.K.), Hti Medical Inc. (U.S.), Teco Diagnostics (U.S.), Tenko Medical System Corp (U.S.), Wama Diagnostica (Brazil)
Market Development
Regional Analysis
Geographically, the countries covered in the urinalysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in urinalysis market during the forecast period 2020 - 2027
In 2019, North America dominated the urinalysis market because of the increased use of urinalysis for the treatment of liver disease and urinary tract infections Furthermore, the growing number of Urinalysis patients will drive the region's urinalysis market growth during the forecast period.
Asia-Pacific is estimated to be the fastest-growing region in urinalysis market the forecast period 2020 - 2027
Asia-Pacific is expected to grow during the forecast period due to the rise in the initiatives taken by the government for the awareness related to the significance of diagnosis.
COVID-19 Impact Analysis
The COVID-19 pandemic had a significant impact on the urinalysis market. COVID-19 patients are more likely to suffer from acute kidney injury (AKI), which can result in serious health complications, including death. As a result, patients should consult with a nephrologist on a regular basis to avoid further health issues. Companies have made strategic decisions to carry out COVID-19 rapid tests, maintain revenues, and limit the impact of COVID-19 on their operating capabilities in the post-COVID scenario.
For more detailed information about the urinalysis market report, click here – https://www.databridgemarketresearch.com/reports/global-urinalysis-market
Global Urinalysis Market - Industry Trends and Forecast to 2029
North America Urinalysis Market – Industry Trends and Forecast to 2030
Europe Urinalysis Market – Industry Trends and Forecast to 2030
Asia-Pacific Urinalysis Market – Industry Trends and Forecast to 2029
Middle East and Africa Urinalysis Market – Industry Trends and Forecast to 2030
Global Point of Care (POC) Urinalysis Market – Industry Trends and Forecast to 2030